- Home
- SLGL vs EMIS Comparison
SLGL vs EMIS Comparison
Compare SLGL & EMIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$71.94
N/A
Current Price
$10.02
Company Overview
Basic Information| Metric | SLGL | EMIS |
|---|---|---|
| Founded | 1997 | 2024 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.7M | 157.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLGL | EMIS |
|---|---|---|
| Price | $71.94 | $10.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | ★ 29.6K | 18.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $122.71 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.02 | $9.90 |
| 52 Week High | $76.80 | $11.11 |
Technical Indicators
Market Signals| Indicator | SLGL | EMIS |
|---|---|---|
| Relative Strength Index (RSI) | 64.66 | 47.99 |
| Support Level | $62.08 | $10.03 |
| Resistance Level | $76.80 | $10.08 |
| Average True Range (ATR) | 6.90 | 0.01 |
| MACD | 0.42 | -0.01 |
| Stochastic Oscillator | 81.33 | 22.22 |
Price Performance
Historical Comparison SLGL
EMIS
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About EMIS Emmis Acquisition Corp. Class A Ordinary Shares
Emmis Acquisition Corp is a blank check company.